 <h1>Anectine Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>succinylcholine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about succinylcholine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Anectine.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to succinylcholine: parenteral injection</i></p><h3>Warning</h3><p><ul>
Rhabdomyolysis with Hyperkalemia
<li>
Risk of acute rhabdomyolysis with hyperkalemia followed by ventricular arrhythmias, cardiac arrest, and death in apparently healthy children and adolescents who subsequently were found to have undiagnosed skeletal muscle myopathy (e.g., Duchenne’s muscular dystrophy).&lt;sup&gt;100&lt;/sup&gt;</li></ul></p><ul>
Rhabdomyolysis with Hyperkalemia
<li>
Risk of acute rhabdomyolysis with hyperkalemia followed by ventricular arrhythmias, cardiac arrest, and death in apparently healthy children and adolescents who subsequently were found to have undiagnosed skeletal muscle myopathy (e.g., Duchenne’s muscular dystrophy).&lt;sup&gt;100&lt;/sup&gt;</li></ul><p>
<li>
Use in children and adolescents should be reserved for those undergoing emergency intubation, those in whom an airway should be secured immediately (e.g., patients with laryngospasm, difficult airway, or full stomach), or those in whom a suitable vein is not accessible and IM administration is needed.&lt;sup&gt;100&lt;/sup&gt;  (See Pediatric Use under Cautions.)</li></p><p>
<ul>
Experience of Clinician
<li>
Should be administered only by individuals experienced in the use of neuromuscular blocking agents.&lt;sup&gt;100&lt;/sup&gt;</li></ul></p><ul>
Experience of Clinician
<li>
Should be administered only by individuals experienced in the use of neuromuscular blocking agents.&lt;sup&gt;100&lt;/sup&gt;</li></ul><p></p><p>Side effects include:</p><p>Various degrees of skeletal muscle weakness.</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to succinylcholine: compounding powder, injectable powder for injection, injectable solution, intravenous solution</i></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Anaphylaxis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Muscle fasciculation, post-operative muscle pain</p><p><b>Common</b> (1% to 10%): Myoglobinemia, myoglobinuria</p><p><b>Rare</b> (less than 0.1%): Trismus </p><p><b>Frequency not reported</b>: Rhabdomyolysis, myoglobinuria, myoglobinemia, elevated creatine phosphokinase, hypertonia, precipitation or exacerbation of myasthenia gravis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Increased intraocular pressure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperkalemia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Bronchospasm, prolonged respiratory depression, apnea </p><p><b>Very rare</b> (less than 0.01%): Increased bronchial secretions, pulmonary edema (in infants)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very rare</b> (less than 0.01%): Malignant hyperthermia, porphyria<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal failure<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Bradycardia, tachycardia, flushing, hypertension, hypotension</p><p><b>Rare</b> (less than 0.1%): Arrhythmias (including ventricular arrhythmia), cardiac arrest, hyperkalemia-related cardiac arrest (following administration to patients with congenital cerebral palsy, tetanus, Duchenne muscular dystrophy, and closed head injury)</p><p><b>Frequency not reported</b>: Circulatory collapse, shock<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Increased intragastric pressure, excessive salivation</p><p><b>Frequency not reported</b>: Increased bowel movements, increased gastric secretions<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Quelicin Chloride (succinylcholine)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_3">3. "Product Information. Anectine (succinylcholine)." Glaxo Wellcome, Research Triangle Park, NC. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Anectine (succinylcholine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>1 Review</li>
<li>Generic Availability</li>
<li>Drug class: neuromuscular blocking agents</li>
<li>FDA Alerts (4)</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>